Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study of the EBMT (RICMAC trial)

Kroeger, Nicolaus; Iacobelli, Simona; Franke, Georg-Nikolaus; Platzbecker, Uwe; Uddin, Ruzena; Huebel, Kai; Scheid, Christof; Weber, Thomas; Robin, Marie; Stelljes, Matthias; Afanasyev, Boris; Heim, Dominik; Deliliers, Giorgio Lambertenghi; Onida, Francesco; Dreger, Peter; Pini, Massimo; Guidi, Stefano; Volin, Liisa; Guenther, Andreas; Bethge, Wolfgang; Poire, Xavier; Kobbe, Guido; van Os, Marleen; Brand, Ronald; de Witte, Theo

Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study of the EBMT (RICMAC trial)

Autor(en):

Kroeger, Nicolaus; Iacobelli, Simona; Franke, Georg-Nikolaus; Platzbecker, Uwe; Uddin, Ruzena; Huebel, Kai; Scheid, Christof; Weber, Thomas; Robin, Marie; Stelljes, Matthias; Afanasyev, Boris; Heim, Dominik; Deliliers, Giorgio Lambertenghi; Onida, Francesco; Dreger, Peter; Pini, Massimo; Guidi, Stefano; Volin, Liisa; Guenther, Andreas; Bethge, Wolfgang; Poire, Xavier; Kobbe, Guido; van Os, Marleen; Brand, Ronald; de Witte, Theo

Tübinger Autor(en):

Bethge, Wolfgang Andreas

Erschienen in:

Journal of Clinical Oncology (2017), Bd. 35, H. 19, S. 2157-2164

Verlagsangabe:

Amer Soc Clinical Oncology

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1200/JCO.2016.70.7349

ISSN:

1527-7755